Par Health launches generic version of Janumet XR tablets in US

FDA approves Furoscix ReadyFlow for at-home treatment of edema

CHMP backs Gilead's Trodelvy-Keytruda combination for first-line metastatic triple-negative breast cancer

FDA grants Fast Track designation to Lundbeck's narcolepsy candidate Lu AH69593

Scancell and Neuphoria agree merger

Eurofins Viracor introduces BKV inSIGHT T-cell immunity panel for BK virus immune monitoring in kidney transplant patients

GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC

Hugel Aesthetics expands US presence

European Commission expands Crysvita approval to infants with XLH

AbelZeta's C-CAR168 receives EMA PRIME designation for Lupus Nephritis and Systemic Lupus Erythematosus

Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date

Vanda Pharmaceuticals reports positive EMA opinion on orphan drug designation for imsidolimab in generalised pustular psoriasis

World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601

Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial

MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA